Abstract
Introduction
Neisseria meningitidis is a gram-negative bacterium responsible for life-threatening invasive infections known as invasive meningococcal disease and is associated with high fatality rates and serious lifelong disabilities among survivors.Methods
This study aimed to characterize N. meningitidis isolates cultured from blood and cerebrospinal fluid collected between 2009 and 2021 in Lithuania, assess their genomic relationships with European strains, and evaluate the possibility of using a cost-effective method for strain characterization, thus improving the national molecular surveillance of invasive meningococcal disease. In total, 321 N. meningitidis isolates were collected and analyzed using multilocus restriction typing (MLRT). Amplification of the penA gene and restriction fragment length polymorphism analysis were performed to identify the modified penA genes. Based on the MLRT genotyping results, we selected 10 strains for additional analysis using whole-genome sequencing. The sequenced genomes were incorporated into a dataset of publicly available N. meningitidis genomes to evaluate genomic diversity and establish phylogenetic relationships within the Lithuanian and European circulating strains.Results
We identified 83 different strains using MLRT genotyping. Genomic diversity of N. meningitidis genomes analysed revealed 21 different sequence types (STs) circulating in Lithuania. Among these, ST34 was the most prevalent. Notably, three isolates displayed unique combinations of seven housekeeping genes and were identified as novel STs: ST16969, ST16901, and ST16959. The analyzed strains were found to possess virulence factors not commonly found in N. meningitidis. Six distinct penA profiles were identified, each with different frequencies. In the present study, we also identified N. meningitidis strains with new penA, NEIS0123, NEIS1320, NEIS1525, NEIS1600, and NEIS1753 loci variants. In our study, using the cgMLST scheme, Minimum Spanning Tree (MST) analysis did not identify significant geographic relationships between Lithuanian N. meningitidis isolates and strains from Europe.Discussion
Discussion: To our knowledge, this is the first study to employ whole genome sequencing (WGS) method for a comprehensive genetic characterization of invasive N. meningitidis isolates from Lithuania. This approach provides a more detailed and precise analysis of genomic relationships and diversity compared to prior studies relying on traditional molecular typing methods and antigen analysis.Free full text
Genetic characterization of Neisseria meningitidis isolates recovered from patients with invasive meningococcal disease in Lithuania
Abstract
Introduction
Neisseria meningitidis is a gram-negative bacterium responsible for life-threatening invasive infections known as invasive meningococcal disease and is associated with high fatality rates and serious lifelong disabilities among survivors.
Methods
This study aimed to characterize N. meningitidis isolates cultured from blood and cerebrospinal fluid collected between 2009 and 2021 in Lithuania, assess their genomic relationships with European strains, and evaluate the possibility of using a cost-effective method for strain characterization, thus improving the national molecular surveillance of invasive meningococcal disease. In total, 321 N. meningitidis isolates were collected and analyzed using multilocus restriction typing (MLRT). Amplification of the penA gene and restriction fragment length polymorphism analysis were performed to identify the modified penA genes. Based on the MLRT genotyping results, we selected 10 strains for additional analysis using whole-genome sequencing. The sequenced genomes were incorporated into a dataset of publicly available N. meningitidis genomes to evaluate genomic diversity and establish phylogenetic relationships within the Lithuanian and European circulating strains.
Results
We identified 83 different strains using MLRT genotyping. Genomic diversity of N. meningitidis genomes analysed revealed 21 different sequence types (STs) circulating in Lithuania. Among these, ST34 was the most prevalent. Notably, three isolates displayed unique combinations of seven housekeeping genes and were identified as novel STs: ST16969, ST16901, and ST16959. The analyzed strains were found to possess virulence factors not commonly found in N. meningitidis. Six distinct penA profiles were identified, each with different frequencies. In the present study, we also identified N. meningitidis strains with new penA, NEIS0123, NEIS1320, NEIS1525, NEIS1600, and NEIS1753 loci variants. In our study, using the cgMLST scheme, Minimum Spanning Tree (MST) analysis did not identify significant geographic relationships between Lithuanian N. meningitidis isolates and strains from Europe.
Discussion
Discussion: To our knowledge, this is the first study to employ whole genome sequencing (WGS) method for a comprehensive genetic characterization of invasive N. meningitidis isolates from Lithuania. This approach provides a more detailed and precise analysis of genomic relationships and diversity compared to prior studies relying on traditional molecular typing methods and antigen analysis.
1. Introduction
Neisseria meningitidis, a prevalent gram-negative bacterial commensal in the human upper respiratory tract, is also capable of causing large epidemics of invasive meningococcal disease (IMD) (Stephens et al., 2007). N. meningitidis, which asymptomatically colonizes the nasopharynx in approximately 10% of healthy individuals, remains the main cause of meningitis and fulminant sepsis worldwide (Tzeng and Stephens, 2021). The transition from asymptomatic to invasive disease remains unclear. However, certain factors, such as the genetic and capsular structures of pathogenic strains, are thought to play a significant role (Mullally et al., 2021).
The distribution of serogroups of N. meningitidis shows significant variation worldwide, with six capsular types (A, B, C, W, X, and Y) responsible for most meningococcal disease cases (Lu et al., 2019). Although the capsule is the main factor determining the virulence of N. meningitidis, comparative genomic studies have revealed the presence of additional genomic factors in various lineages (Caugant and Maiden, 2009). Natural competence for genetic transformation and homologous recombination contribute to the extensive genomic diversity of meningococcal lineages, with recombination being the principal mechanism for introducing new genetic information (Schoen et al., 2009). Numerous factors have been linked to the pathogenesis of N. meningitidis, including increased invasiveness, overcoming host defenses, and resistance to antimicrobial treatment. Therefore, a comprehensive understanding of the adaptive and pathogenic mechanisms of N. meningitidis is important (Lu et al., 2019).
Molecular profiling of N. meningitidis is vital for global control of the disease. Genomic surveillance of bacterial meningitis pathogens facilitates the detection of emerging and spreading strains, leading to public health interventions (Rodgers et al., 2020). Over the past 10 years, in many European countries, epidemiological surveillance of N. meningitidis has been based on whole-genome sequencing (WGS) methods. The accessibility of WGS provides an opportunity to understand the biology and diversity of N. meningitidis (Bratcher et al., 2014). However, while WGS is employed in countries with the necessary capacity and resources, in middle- or low-income countries, not only is the WGS methodology not in use, but simpler genotyping techniques, such as multilocus sequence typing (MLST), are not applied. Typically, methods with low discriminatory power, such as slide agglutination serogrouping or polymerase chain reaction (PCR)-based techniques for serogroup prediction, are used for epidemiological surveillance of infectious diseases in Lithuania. Importantly, at the national level for routine surveillance of meningococcal disease, comprehensive typing methods like MLST, considered a principal method for detailed molecular characterization, are not routinely employed. MLST analysis is typically conducted retrospectively by research groups (Sereikaitė et al., 2023; Ivaškevičienė et al., 2023) rather than as part of standard surveillance protocols. This does not ensure proper identification and typing of pathogens isolated during outbreaks/epidemics, transmission dynamics, risk factor identification, pathogenesis, and the etiologic attribution of pathogens; thus, it is not known whether isolates causing invasive diseases belong to the same virulent strain or if they are different strains (Eybpoosh et al., 2017).
The epidemiology of IMD varies geographically and over time (Tzeng and Stephens, 2021) and is influenced by meningococcal vaccines and isolation measures employed during the COVID-19 pandemic in 2020–2021 (Alderson et al., 2022).
Compared to other European countries, the epidemiological situation in Lithuania has been challenging for several years. The number of IMD cases reported in Lithuania from 2009 to 2020 (median, 1.65 per 100,000 inhabitants) was higher than that reported in other European countries (median, 0.63 per 100,000 inhabitants). During the period from 2009 to 2012, the average notification rate of IMD cases was 1.47 cases per 100,000 population. From 2013 to 2017, the average rate increased to 2.20 cases per 100,000 population. Although 2018 showed a significant decrease in the number of notified IMD cases (1.10 cases per 100,000 population in 2017), it was marked by the highest case fatality rate in the past 10 years, reaching as high as 21.74%. A relatively high case fatality rate persisted in 2019 at 18.75%. The lowest number of notified IMD cases (0.25–0.39 per 100,000 population) and no associated fatalities were observed in 2020 and 2021 (European Centre for Disease Prevention and Control, 2023). Therefore, it is critically important to investigate the genotypic relationship of Lithuanian isolates with strains isolated in Europe to gain insights that can inform effective public health interventions.
2. Methods
2.1. Source of isolates
In total, 321 strains of N. meningitidis acquired from the National Public Health Surveillance Laboratory in Lithuania were examined. The isolates were collected from patients diagnosed with IMD between October 12, 2009, and August 25, 2021. Among them, 207 (64.5%) were isolated from blood and 114 (35.5%) from cerebrospinal fluid. Pure N. meningitidis cultures were stored at -80°C in tryptone soy broth containing 20% horse blood serum and 15% glycerol. To recover the isolates from long-term storage, 10 μL of freezing medium was transferred to Mueller–Hinton chocolate agar plates, and the isolates were incubated on the plates at 37°C with humidity for 18–24 h in an atmosphere of 5% CO2. A single colony from a visually pure culture of each N. meningitidis isolate was selected for subsequent analysis.
2.2. Antibiotic susceptibility testing
Minimum inhibitory concentrations (MIC) for penicillin G, cefotaxime, rifampicin, and ciprofloksacin were determined using Liofilchem® MIC gradient strips (Liofilchem S.r.l., Italy) and interpreted according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints v13.1 (The European Committee on Antimicrobial Susceptibility Testing, 2023). Antimicrobial susceptibility testing was performed on Mueller–Hinton agar supplemented with 5% defibrinated sheep blood (Liofilchem S.r.l., Italy) and incubated at 35–37°C in 5% CO2. For quality control, Streptococcus pneumoniae ATCC 49619 and Escherichia coli ATCC 25922 were used.
To compare the MIC values between the different groups, the Kruskal–Wallis test was applied. The data obtained were analyzed using IBM SPSS statistics software (version 21), and statistical significance was set at p < 0.05.
2.3. Genomic DNA extraction
The total DNA of N. meningitidis strains was extracted from suspended single bacterial colonies using a GeneJET Genomic DNA Purification Kit (Thermo Fisher Scientific Inc.), following the manufacturer’s protocol. DNA quality was assessed by measuring absorbance at 260/280nm, and integrity was verified using 1% agarose gel electrophoresis.
2.4. Characterization of isolates
To confirm the identity of N. meningitidis and determine its serogroup, all isolates underwent PCR analysis. Meningococcus-specific genes (porA and ctrA) and genes specific to the serogroup (sacD, siaD, cap29EH, wnmB, capZC, lcbB, xcbA, wnmA, synG, and galE/lipA) were targeted as previously described (Zhu et al., 2012.). Amplification products were separated on a 1% agarose gel. Genogroups for all publicly available N. meningitidis genomes from Lithuania were extracted from the pubMLST database.
All N. meningitidis strains were analyzed using multilocus restriction typing (MLRT), which was performed as described by Benett et al (Bennett and Cafferkey, 2003). MLRT involves the restriction fragment length polymorphism analysis of PCR products obtained from seven housekeeping gene loci used in MLST (Maiden et al., 1998). PCR products were digested with MspI and MnlI (Thermo Fisher Scientific Inc.) restriction endonucleases according to the manufacturer’s instructions and analyzed by 1% agarose gel electrophoresis. Alleles at each of the seven loci were combined to obtain an allelic profile or restriction type (RT). All RT were manually scored and analyzed. A dendrogram was constructed using Hierarchical Clustering—Unweighted Pair-Group Method with Arithmetic Averages (UPGMA) (Garcia-Vallvé et al., 1999) and visualized using interactive Tree of Life (iTOL) (Letunic and Bork, 2021).
Amplification of the penA gene and restriction fragment length polymorphism (RFLP) analysis were performed to identify the modified penA genes, following the method described by Antignac et al (Antignac et al., 2001). The penA PCR products were treated with restriction endonuclease TaqI (Thermo Fisher Scientific Inc.) according to the manufacturer’s instructions and assessed by 1% agarose gel electrophoresis. To evaluate the relationship between penA RFLP and penA sequencing methods, we analyzed data of publicly available isolates from Lithuania in the PubMLST database (Jolley et al., 2018). Additionally, we used a BLASTn search against the NCBI nr database to detect homology between rarely detected penA alleles and penA genes of other Neisseria species. To identify penA sequence differences between strains and mutations associated with penicillin resistance, we conducted a multiple sequence alignment using Jalview (version 2.11.3.3) (Waterhouse et al., 2009), employing MAFFT with default settings. Based on the MLRT genotyping results, we selected 10 distinct strains for additional analysis using WGS ( Table 1 ). The dendrogram representing genetic variation among 321 isolates of N. meningitidis based on MLRT analysis was instrumental in helping us objectively select different strains. Sub-clustering had a major impact on the strain selection process. First, we chose at least two strains (one isolated from blood and one from CSF) from each of the three largest sub-clusters. Secondly, we selected at least two distinct serogroups from each sub-cluster. Additionally, we included rarely identified serogroups (Y, E, NG). We did not choose strains from cluster 1 because we assumed the risk that these strains were from patients with weakened immune systems (patient age >64 years). Additionally, isolates from sub-cluster 3 were recently analyzed by other scientists in Lithuania (Sereikaitė et al., 2023). We did not specifically select for specific restriction types. However, almost all the selected strains had unique restriction types (frequency of 1), with only one strain selected from the most commonly identified restriction type, RT1.
Table 1
pubMLST ID | Year | Source | Patient age range | Genogroup | MLRT sub-cluster | RT (MLRT) |
---|---|---|---|---|---|---|
120132 | 2014 | Blood | 45-64 | C | 1 | 19 |
120136 | 2016 | Cerebrospinal fluid | 25-44 | B | 1 | 49 |
120133 | 2015 | Blood | 15-24 | B | 2 | 27 |
120134 | 2016 | Blood | 25-44 | B | 2 | 43 |
120135 | 2016 | Blood | 15-24 | E | 2 | 45 |
120139 | 2017 | Cerebrospinal fluid | 15-24 | Y | 2 | 76 |
120140 | 2021 | Blood | 45-64 | B | 2 | 83 |
119504 | 2011 | Cerebrospinal fluid | 45-64 | B | 4 | 1 |
120137 | 2016 | Blood | 15-24 | NG | 4 | 50 |
120138 | 2017 | Blood | 45-64 | B | 4 | 58 |
2.5. Bioinformatic analyses
The extracted DNA was sent to Novogene services (https://www.novogene.com/eu-en) for whole genome sequencing using the Illumina NovaSeq 6000 sequencing system and subsequent genome assembly. A paired-end sequencing strategy was used to sequence the samples. The coding genes were predicted using Augustus software (version 2.7) with homologous evidence. The scaffolds were subjected to RAST annotation server (Overbeek et al., 2014). Draft genomes of the described N. meningitidis strains were submitted to the PubMLST database (Jolley et al., 2018) with the following accession numbers: 119504, 120132, 120133, 120134, 120135, 120136, 120137, 120138, 120139, and 120140.
Phylogenetic networks were created for the invasive isolates of N. meningitidis from Lithuania (n = 43), which were the only genomes available in the PubMLST (Jolley et al., 2018) database until October 9, 2023. Of these, 10 genomes were sequenced in our study, and 33 genomes were submitted earlier. iTOL (Letunic and Bork, 2021) was used to construct neighbor-joining trees using concatenated nucleotides of the core-genome MLST (cgMLST) loci. Loci with paralogous hits within isolates were excluded from analysis.
A minimum spanning tree (MST) was created for a collection of 9490 N. meningitidis isolates using the GrapeTree tool on the PubMLST website (Jolley et al., 2018). The tree was constructed based on a cgMLST v2 scheme and was color-coded according to the country of isolation. The analysis specifically included invasive isolates collected in Europe.
tRNA, rRNA, sRNAs, Interspersed Repeat, and Tandem Repeat were predicted by Novogene.
The predicted protein-coding genes were mapped to the Kyoto Encyclopedia of Genes and Genomes (KEGG) using BLASTKOALA and the KEGG Mapper Reconstruction web server (Kanehisa et al., 2016).
The subcellular localization of the proteins was predicted using PSORTb version 3.0 (Yu et al., 2010). Putative adhesion domains in the encoded amino acid sequences were determined using the Pfam database (Mistry et al., 2021). We conducted a literature review to identify experimentally validated bacterial adhesins, such as performing a keyword search for “adhesin,” “adherence,” “adhesion,” “adhesive,” “chitin binding,” “collagen binding,” “laminin binding,” “mucin binding,” “membrane adhesin,” “Neisseria adhesin,” “pilin,” “pilus,” “autotransporter,” “polysaccharide capsule,” “porin,” and “two-partner secretion” in the InterPro 96.0 database (Paysan-Lafosse et al., 2023).
To verify the pathogenicity and virulence factors, PathogenFinder v1.1 (Cosentino et al., 2013) and the Virulence Factor Database (VFDB) (Liu et al., 2019) were used. Antimicrobial resistance genes were identified using Resistance Gene Identifier from CARD (Alcock et al., 2020), and alleles linked to reduced antibiotic susceptibility were detected using the genome comparator tool in PubMLST (Jolley et al., 2018).
3. Results
3.1. N. meningitidis serogrouping
The 321 N. meningitidis isolates were serogrouped, and the distribution of serogroups determined by PCR methods was as follows: 292 (91.0%) were serogroup B, 23 (7.2%) were serogroup C, 3 (0.9%) were serogroup Y, 1 (0.3%) was serogroup W135, 1 (0.3%) was serogroup E, and 1 (0.3%) was non-groupable ( Supplementary Table S1 ).
3.2. Antibiotic susceptibility testing
All the N. meningitidis isolates were susceptible to penicillin, cefotaxime, rifampicin, and ciprofloxacin ( Supplementary Table S1 ).
3.3. N. meningitidis genetic diversity
3.3.1. MLRT analysis
Several restriction patterns (alleles) were observed for each of the seven loci examined, indicating polymorphisms at these loci ( Figure 1 ). The number of alleles varied between four in adk, the most conserved locus, and 14 in pgm, suggesting different evolution rates for different loci.
Of the 321 strains examined, 83 different RTs were identified; their interrelationships are illustrated in the dendrogram ( Figure 2 ). The UPGMA dendrogram illustrated genetic variation among the isolates, categorizing them into three major clusters. Cluster 1 consisted of only two isolates. Clusters 2 and 3 were further divided into two subclusters. Subclusters 1, 2, 3, and 4 were again divided into groups. The first, second, third, and fourth groups included 4, 33, 4, and 39 isolates, respectively. The fifth group comprised only 1 isolate. The sixth group comprised 2 isolates, the seventh group consisted of 93 isolates, and the eighth group included the largest number of isolates (143). Phylogenetic analyses of the isolates revealed that each subcluster consisted of N. meningitidis isolates from various isolation years, sites, and patient age groups ( Figure 2 ). No significant patterns related to the isolation year, site, or patient age group could be inferred from this clustering. Based on the MLRT genotyping results, we chose 10 distinct strains for molecular characterization using WGS to elucidate evolutionary dynamics, assess regional prevalence, and classify strains more precisely, while also identifying genetic markers and inferring transmission pathways to gain comprehensive insights into emerging strains for enhanced public health understanding and preparedness. The dendrogram was instrumental in helping us objectively select different strains. Sub-clustering had a major impact on the strain selection process, providing additional context and validation for our choices.
To evaluate the relationship between MLRT and MLST genotyping methods, we analyzed data from 10 sequenced isolates and 33 publicly available isolates from Lithuania in the pubMLST database. The distribution of RT, ST, and CC is outlined in the Supplementary Table S2 . We identified some discrepancies between the identified RTs and STs. The strains marked as RT1, RT15, and RT20 were identified as ST34 according to the MLST method. RT15 differs from RT1 by one allele in two loci, adk and gdh. RT20 differs from RT1 by one allele in the gdh locus.
Although there is some discrepancy between the identified RTs and STs, the clonal relationships among N. meningitidis strains are clearly delineated. In our MLRT and MLST comparison analysis, we identified that all strains marked as RT1, RT15, RT20, RT29, and RT70 belonged to the ST-32 complex. According to the MLRT genotyping method, all these strains have identical alleles in the aroE, fumC, phdC, and pgm loci. According to the MLST method, all strains belonging to the ST-32 complex have identical alleles in the adk, fumC, pdhC, and pgm loci. It is noteworthy that during the visual assessment of electrophoresis, there were doubts in distinguishing allele 2 from allele 3 in the adk locus, which might be the cause of the discrepancies.
The strain marked as RT50 was associated with the ST-11 complex, while RT19 and RT49 belonged to the ST-18 complex. Strains marked as RT27 and RT82 were found to be part of the ST-213 complex, and RT76 belonged to the ST-23 complex. Additionally, RT28, RT77, and RT78 were classified within the ST-41/44 complex. Notably, the strain marked as RT17 was the only strain to belong to two distinct clonal complexes: ST-18 (n=2, 66.7%) and ST-32 (n=1, 33.3%).
Our analysis revealed that certain RTs belonged to specific clonal complexes, suggesting that MLRT can serve as a predictor for MLST clonal complexes in our dataset.
3.3.2. penA analysis
Amplification of the penA gene and RFLP analysis were performed to identify the modified penA genes. Amplification products were obtained for all analyzed strains. Subsequent digestion with TaqI and separation on a 1% agarose gel resulted in the identification of six distinct profiles ( Figure 3A ). A unique identifier was assigned to each profile and labeled patterns 1–6. Among them, penA 1 (71.88%, n = 230) was the most prevalent, followed by penA 2 (22.19%, n = 71). The distribution of different penA restriction patterns in the Lithuanian N. meningitidis strains is shown in Figure 3B .
The penicillin MIC values in isolates with penA 1 (range: 0.016–0.250 mg/L, median = 0.125) were significantly higher than those in isolates with penA 2 (range: 0.016–0.190 mg/L, median = 0.023) and penA 4 (range: 0.016–0.047 mg/L, median = 0.023) patterns (p < 0.001) ( Supplementary Table S1 ). None of the isolates analyzed were resistant to penicillin.
To evaluate whether the penA RFLP method used in this study could help identify different penA gene modifications, we compared the results with sequencing data from 10 isolates and included an additional 33 publicly available isolates from Lithuania in the pubMLST database. In total, 11 distinct penA gene alleles were identified. The penA52 allele constituted the majority of the analyzed isolates (55.80%, n=24). Notably, all isolates with the penA52 allele in our study were identified as having the penA1 restriction pattern. The distribution of penA gene alleles and their comparison with the penA RFLP method results are presented in the Supplementary Table S2 .
3.3.3. cgMLST analysis
The genomic diversity of N. meningitidis in Lithuania was investigated by analyzing a set of 10 strains specifically examined in this study. To obtain a more thorough and detailed insight into genomic diversity, an additional 33 publicly available genomes collected between 2011 and 2021 were included. All genomes were derived from human sources and associated with invasive infections ( Figure 4 ).
Our analysis revealed 21 sequence types (STs) circulating in Lithuania. The most prevalent was ST34 (76.19%, n = 16), followed by ST9775 (19.05%, n = 4) and ST9779 (14.29%, n = 3). Other STs, such as ST213 and ST15967, were detected in at least two genomes, whereas 16 different STs were observed in individual genomes.
Notably, three isolates (ID 120132, 120136, and 120140) displayed unique combinations of seven housekeeping genes and were designated as novel STs upon submission to the PubMLST database. Specifically, isolate 120132 had a novel ST16969 profile, isolate 120136 had an ST16901 profile, and isolate 120140 had an ST16959 profile. Isolate 120132 was obtained from the blood of a 47-year-old male, isolate 120136 from the cerebrospinal fluid (CSF) of a 40-year-old female, and isolate 120140 from the blood of a 46-year-old male.
3.3.4. Comparison of local genomic epidemiology with international genomic epidemiology using the cgMLST scheme
Incorporating all Lithuanian isolates into a dataset of publicly accessible N. meningitidis genomes allowed the evaluation of their genomic diversity and phylogenetic relationships with circulating strains in Europe. Currently, the dataset is predominantly composed of isolates from the United Kingdom (n = 5726), the Netherlands (n = 684), Germany (n = 534), and France (n = 530), contrasting with other European countries, several of which have fewer than 10 sequenced isolates as of the analysis date (e.g., Portugal, Latvia, and Cyprus). Using the cgMLST scheme, the MST of 9490 N. meningitidis strains from various European countries revealed no significant geographic relationships. A widespread dissemination of N. meningitidis strains was observed within the European region, with the root of the MST originating in Sweden and the United Kingdom. The examined isolates belonged to 43 clonal complexes, with the majority composed of the ST-11 complex (26.0%) and the ST-41/44 complex (16.7%). In Lithuania, however, the ST-32 complex was predominant (58.1%), contrasting with its lower prevalence (7.5%) in the broader European region. Out of the 9490 analyzed isolates, 814 (8.6%) were not assigned to a clonal complex. Of the 10 Lithuanian isolates analyzed in this study, eight belonged to different clades of relatedness, while only two strains (ID 120132 and 120136) were closely related ( Figure 5 ).
MST demonstrated that the Lithuanian ST-32 complex isolates (n = 25), including the isolate analyzed in this study (ID 119504), were genetically related and formed a single clade, along with isolates from various European countries. The newly identified STs, ST16969 (ID 120132) and ST16901 (ID 120136), were closely related to an isolate found in England in 2016 (ID 53173) and belongs to ST18. Additionally, several isolates from Lithuania exhibited close genetic relationships with isolates from England, Northern Ireland, Poland, and the Czech Republic, indicating potential transmission events and genetic exchange across borders. Supplementary Figures S1, S2 illustrate the genetic relationships between N. meningitidis strains from Lithuania and those circulating in Europe.
3.4. Analysis of WGS data
In this study, ten draft genomes of N. meningitidis strains were used. The characteristics of the assembled genome are listed in Supplementary Table S3 . The number of scaffolds per genome assembly varied from 70 to 121, and the N50 values were between 29,431 and 55,311 base reads. The average genome size of the 10 strains was 2,163,040 bp, ranging from 2,060,116 bp (ID 120137) to 2,283,261 bp (ID 120136). The average GC content of all the genomes was 51.66%, ranging from 51.46% (ID 120138) to 51.95% (ID 120137).
The average number of coding genes predicted by Augustus (version 2.7) was 2178, ranging from 2082 (ID 120137) to 2305 (ID 120136). In contrast, the average number of CDSs by RAST was 2567, ranging from 2429 (ID 120137) to 2729 (ID 120136). Only 28–31% of CDSs in each strain could be functionally categorized into subsystems. In all studied strains, subsystems such as protein metabolism, amino acids and derivatives, cofactors, vitamins, prosthetic groups, and pigments were found to have a higher number of functional genes. No genes associated with potassium metabolism, motility, or chemotaxis were detected in any strain. Supplementary Table S3 and Supplementary Figure S3 provide a comprehensive overview of the genome characteristics of N. meningitidis strains and their subsystem statistics.
Based on KEGG analysis, the CDSs were categorized into six sub-categories. The strains conserved 1264 (ID 120137) to 1288 (ID 120136) CDSs, which were further classified into 40 functional KEGG subcategories. It is worth mentioning that all strains exhibited a noticeably higher abundance of genes associated with metabolic pathways (CDSs 783–803), followed by genetic information processing (CDSs 183–186) and human diseases (CDSs 106–112) ( Supplementary Table S4 ). Pathway modules ( Supplementary Table S5 ) showed high similarity across strains, with few differences observed. The exclusive metabolic features detected in strains 120136, 120139, and 120140 were complete pathways for dTDP-L-rhamnose biosynthesis. In other strains, this pathway was either not detected (119504 and 120133) or was incomplete (120132, 120134, 120135, 120137, and 120138). Incomplete pathways for Shikimate and Siroheme biosynthesis were observed in strains 120134 and 120137, respectively.
3.4.1. Genetic factors encoding adhesion properties
Exploration of extracellular proteins or outer membrane-attached proteins encoded within the genomes of the analyzed strains, as indicated by PSORTb, revealed an average of 66 proteins (range: 62–77). Additionally, all genomes were examined for the presence of adhesion-related domains. We identified 50 distinct adhesion-related domains. The subsequent domains were found in all strains: PF03865 and PF13018. The following domains were exclusively detected in strain ID 120139: PF06122, PF05309, PF06834, and PF09673. The results of identifying adhesion-related domains and their frequencies in the analyzed genomes are presented, and a complete list of domains detected using the Pfam database can be found in Supplementary Tables S6, S7 . Supplementary Table S8 contains a comprehensive list of proteins found in the genomes of N. meningitidis strains, including those located extracellularly, attached to the outer membrane, and putative adhesins in other cellular locations, along with their respective domains, as identified using the Pfam database. From these analyses, we identified genes encoding putative adhesins or adhesion-related proteins. These candidates should be further investigated in future functional studies.
3.4.2. Genome-based assessment of the potential for pathogenicity
The 10 N. meningitidis genomes were screened for pathogenicity and virulence genes using the PathogenFinder server, scoring each strain as a potential human pathogen ( Supplementary Table S3 ). Strain 120134 had the lowest pathogen score of 85.3%. A total of 1732 genes associated with pathogenicity were identified, with nonuniform distribution across the genomes of each strain. Strains 119504 and 120137 exhibited the highest number of detected pathogenicity determinants (656 and 636, respectively), while strain 120133 had the lowest (350). All 10 isolates were positive for 17 pathogenicity determinants, with five of them categorized as hypothetical proteins. The pathogenic determinants present in a single isolate were defined as unique determinants. In total, 873 unique pathogenicity determinants were identified, 383 of which were designated as hypothetical and 237 as putative proteins. Strain 120134 had the fewest unique determinants (29), while strains 119504 and 120137 had the most at 345 and 227, respectively.
The VFDB system confirmed the presence of various virulence genes, categorized into 11 classes, with most genes associated with adherence (46.3%) and iron uptake (17.1%) ( Figure 6 ). Among the identified genes, 57 (69.5%) were present in all analyzed strains. Notably, genes related to antiphagocytosis (rmlC) and endotoxins (lpt6 and kpsF) were exclusively found in Lithuanian isolates analyzed in this study. Isolates 120134 and 120135 lacked the fetA/frpB and pilH genes, respectively, in contrast to the other isolates in this study and the strains stored in the database. Supplementary Table S9 provides a comprehensive overview of the virulence factor genes of the N. meningitidis strains analyzed in this study.
3.4.3. Antibiotic resistance
For all the strains examined, at least one gene or gene mutation leading to resistance to antimicrobial agents was identified. Eight antibiotic resistance genes have been detected that confer resistance to antibacterial free fatty acids, macrolides, cephalosporins, cephamycin, tetracycline, penicillin, disinfecting agents, and antiseptics. Overall, the most common resistance genes detected were farB (90.0%), which mediates resistance to long-chain antibacterial fatty acids, and mtrA (100%), a macrolide antibiotic. The mutation V57M in rpsJ, conferring tetracycline resistance, was observed in strain 120139. However, these factors are not advantageous because they are not the antibiotics of choice for the treatment of IMD. Three strains harbored mutations in N. meningitidis PBP2, conferring resistance to beta-lactam. A complete list of resistance genes detected using the CARD database is provided in Supplementary Table S10 .
We identified allele diversity at all loci among the 11 antibiotic susceptibility genes analyzed using PubMLST. Three isolates harbored alterations in penA, encoding penicillin-binding protein 2, with specific substitutions: isolate ID 119504 had the penA52 allele, isolate ID 120136 had penA686, and isolate ID 120138 had penA1191. In the PubMLST database, only two isolates were found to have the penA686 allele: one from Lithuania and one from Italy (ID 40340), while the penA1191 allele was identified exclusively in the isolates examined in this study. Next, we used BLASTn to detect homologies between rarely detected penA alleles (penA686 and penA1191) and penA genes from other Neisseria species. A BLASTn search against the NCBI nr database yielded hits in other Neisseria species with high (>95%) sequence identity. One of the rarest alleles (penA1191) showed an identity score of 96.51% with the penA gene sequences of N. gonorrhoeae strain NGMAST ST7268 (GenBank accession no. KC192769.1) and N. gonorrhoeae strain 31188 (GenBank accession no. JF893455.1). In the penA686 nucleotide sequence analysis, we found matches with 95.08% identity to the N. gonorrhoeae strain NG9901 penA gene (GenBank accession no. AB608050.1).
The β-lactamase gene (blaROB-1), associated with resistance against β-lactam antibiotics (Hong et al., 2018), was not detected in any analyzed isolates. No alleles linked to resistance to fluoroquinolones (gyrA, NEIS1320, NEIS1525, and NEIS1600) or rifampicin (NEIS0123 and rpoB) were found ( Table 2 ).
Table 2
Locus | pubMLST ID | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
119504 | 120132 | 120133 | 120134 | 120135 | 120136 | 120137 | 120138 | 120139 | 120140 | |
gyrA | 2 | 4 | 3 | 4 | 12 | 11 | 4 | 4 | 1 | 3 |
NEIS0123 | 132 | 41 | 39 | 302 | 218 | 41 | 1 | 2909 | 39 | 2382 |
NEIS0414 | 4 | 1 | 22 | 244 | 168 | 207 | 1 | 1 | 45 | X |
NEIS1320 | 2 | 2216 | 97 | 1 | 174 | 2217 | 159 | 9 | 107 | 2218 |
NEIS1525 | 51 | 50 | 49 | 623 | 2155 | 2156 | 44 | 224 | 70 | 2627 |
NEIS1600 | 22 | 260 | 57 | 289 | 1570 | 1571 | 172 | 202 | 79 | 1572 |
NEIS1635 | 4 | 7 | 7 | 9 | 11 | 7 | 1 | 2 | 7 | 7 |
NEIS1753 | 189 | 2643 | 70 | 205 | 211 | 3498 | 59 | 2644 | 8 | 9 |
NEIS3240 | X | X | X | X | X | X | X | X | X | X |
penA | 52 | 5 | 34 | 1 | 5 | 686 | 1 | 1191 | 22 | 4 |
rpoB | 2 | 1 | 34 | 34 | 5 | 1 | 9 | X | 34 | 34 |
Each locus was assigned an allele number according to its DNA sequence using the PubMLST database.
X – missing alleles.
3.4.3.1. Alterations of PBP2
The complete nucleotide sequences of the NEIS1753 (penA) locus from 10 analyzed isolates were examined to identify alterations in penA gene. These sequences were compared with the N. meningitidis MC58 strain (GenBank accession no. AE002098.2), which harbors the wild-type penA gene, and with the N. meningitidis M99 241997 strain extracted from pubMLST database (ID 89367) and which is resistant to penicillin (MIC=0.64 μg/mL) ( Figure 7 ; Supplementary Figure S4 ). Three isolates harbored different mosaic penA alleles (penA52, penA686, and penA1191). The sequences of the divergent mosaic alleles were 89.55% to 97.94% identical to the wild-type sequence represented by the MC58 strain. Specifically, isolate 119504 showed 97.94% identity, isolate 120136 showed 89.55% identity, and isolate 120138 showed 96.19% identity. This comparison was based on the complete nucleotide sequences of the NEIS1753 (penA) locus. Isolates 119504 and 120138 have slightly increased penicillin resistance (MICs of 0.125 μg/mL and 0.19 μg/mL, respectively).
In the penA C-terminal domain of PBP2 (amino acids 298 to 581), the amino acid sequences were aligned. There are 12 amino acid differences between NmMC58 and Lithuanian isolate ID 119504, 24 differences between NmMC58 and isolate ID 120136, and 14 differences between NmMC58 and isolate ID 120138 ( Supplementary Figure S4 ). All three isolates possessed six penicillin-resistance-associated mutations (F504L, A510V, I515V, H541N, A549T, and I566V). These mutations are also found in the penicillin-resistant strain M99 241997. Additionally, isolates ID 120136 and ID 120138 possessed the E464A, E469K, and N472E substitutions, which were not found in the M99 241997 strain. All these amino acid sites have been previously linked to decreased susceptibility to beta-lactam antibiotics.
Lithuanian isolate ID 119504 and the penicillin-resistant strain M99 241997 have an insertion of a single asparagine amino acid between Thr573 and Ala574 (T573_A574insN) along with a substitution of one amino acid downstream (A574V). The sequences of the penA genes of isolates ID 120132, 120133, 120134, 120135, 120137, 120139, and 120140 were identical to that of the N. meningitidis MC58 strain.
4. Discussion
This study aimed to characterize the isolates of N. meningitidis causing IMD collected in Lithuania from 2009 to 2021. Various techniques were used, including MLRT genotyping, penA gene RFLP analysis, phylogenetic group detection, and WGS analysis.
The epidemiology of IMD has undergone significant changes due to factors like vaccination efforts, environmental conditions, ease of travel, and mass gatherings (Acevedo et al., 2019). Although Europe has seen an increase in serogroup W meningococcus (MenW) and MenY cases (Zografaki et al., 2023), MenB remains the major cause of IMD in Lithuania, with no recent rise in MenW and MenY cases. A rapid decrease in the number of IMD cases was observed shortly after the initiation of the initial lockdown in numerous countries during the COVID-19 pandemic (Brueggemann et al., 2021). A decline in IMD cases was observed in Lithuania starting in 2018, before the COVID-19 pandemic, reflecting the impact of vaccination efforts, including the introduction of the 4CMenB vaccine (Bexsero) into the national immunization program in July 2018. In recent studies conducted in Lithuania, the MenDeVAR Index method (Rodrigues et al., 2021) was used to estimate the predicted coverage of the 4CMenB and MenB-FHbp vaccines. The findings concluded that both serogroup B vaccines demonstrate potential to protect against IMD in Lithuania (Sereikaitė et al., 2023). Importantly, this study analyzed isolates recovered in Lithuania from 2009 to 2019, including the period before vaccination and shortly after the implementation of the 4CMenB vaccine (Bexsero) into the national immunization program in July 2018. Therefore, it is crucial to determine the MenDeVAR index and conduct a comprehensive characterization of N. meningitidis in the post-vaccination period, which would provide valuable insights for public health strategies.
Studies suggest that diverse regional surveillance systems and the evolution of hypervirulent N. meningitidis strains pose a potential threat, potentially increasing IMD incidence (Acevedo et al., 2019). For effective meningococcal disease surveillance, high-resolution, comprehensive, and portable typing schemes are crucial (Jolley et al., 2007). In this study, MLRT method (Bennett and Cafferkey, 2003) was used to characterize N. meningitidis strains, revealing polymorphisms at the examined loci. MLRT genotyping of 321 isolates from Lithuania identified 83 strains, highlighting MLRT’s discriminatory, rapid, and cost-effective nature for N. meningitidis strain characterization. These findings support previous studies characterizing N. meningitidis strains (Bennett et al., 2020). The population of N. meningitidis isolates in Lithuania displayed heterogeneity, consistent with global isolate diversity trends (Caugant and Brynildsrud, 2019). Our results indicate that MLRT method can assist in identifying clonal relationships among N. meningitidis strains associated with meningococcal disease, without the need for expensive equipment or a high level of technical expertise to perform. This simple and cost-effective method can be used as a screening tool to quickly identify newly emerging N. meningitidis strains. It helps in objectively selecting new strains for further analysis using more sensitive techniques like whole-genome sequencing. This approach is particularly useful in countries where advanced methods like MLST genotyping or WGS are not routinely used for epidemiological surveillance.
Treatment options for confirmed IMD typically involve third-generation cephalosporins, penicillin when the strain is susceptible, or chloramphenicol for beta-lactam antibiotic allergies (Nadel, 2016). Recently, strains of N. meningitidis resistant to antibiotics recommended for treatment and chemoprophylaxis have been detected globally (Rostamian et al., 2022). Modifications to penicillin-binding protein 2 reduce its affinity for penicillin, resulting in decreased susceptibility (Acevedo et al., 2019). In this study, we identified six distinct penA profiles using amplification of the penA gene and RFLP analysis, providing a cost-effective method for investigating prevalent penA modifications.
In previous research, geographic variation in the distribution of different penA alleles has been observed (Taha et al., 2007). In 2016, N. meningitidis serogroup B ST-32 complex, which harbored the penA52 allele, was associated with a clonal epidemic of IMD in France (Thabuis et al., 2018). Isolates in Lithuania predominantly harbored the penA52 allele, which this study unequivocally assigned to the penA1 restriction pattern. We found that isolates with the penA1 restriction pattern have a statistically significantly higher penicillin G MIC. Other studies have also observed higher penicillin MIC in strains with the penA52 allele (Hedberg et al., 2009). Notably, pubMLST provides data on the penicillin susceptibility of 72 strains with the penA52 allele. Of these, 19 strains (26.4%) are resistant to penicillin, with penicillin concentrations ranging from 0.064 mg/L to 0.640 mg/L (https://pubmlst.org/).
The meningococcal population structure is diverse and dynamic, with distinct strains grouped into various clonal complexes, some of which are associated with IMD (Caugant and Maiden, 2009). In Lithuania, genomic diversity analysis revealed 21 different circulating STs, with ST34 being the most prevalent (76.19%). Three isolates (ID 120132, 120136, and 120140) displayed unique combinations of housekeeping genes and were identified as novel STs (ST16969, ST16901, and ST16959). Importantly, these isolates with newly identified STs were obtained from adult individuals (ages 40-47 years). It is noteworthy that IMD primarily affects infants in most countries (European Centre for Disease Prevention and Control, 2023).
Using the cgMLST scheme, MST revealed no significant geographic relationships. The ST-32 complex was most prevalent in Lithuania (58.1%) but less so in other European countries (7.9%). Lithuanian isolates in the ST-32 complex formed a distinct clade with isolates from the United Kingdom, Netherlands, Germany, France, Belarus, and Poland. Notably, the most prevalent clonal complex in Lithuania, CC32, is associated with hyperinvasive strains and global outbreaks. N. meningitidis CC32 caused outbreaks in the United Kingdom during the 1980s (Mikucki et al., 2022) and in the United States from 2013 to 2017 (Soeters et al., 2019). This study provides valuable insights into the epidemiological characteristics of IMD in Lithuania. To the best of our knowledge, this is the first study to investigate the genotypic relationship between Lithuanian isolates and strains isolated in Europe with the aim of determining the relatedness of Lithuanian isolates based on core-genome analysis.
Over the last decade, WGS has emerged as a leading technique in clinical microbiology (Purushothaman et al., 2022). The genomes of 10 distinct N. meningitidis strains were analyzed using the advancements offered by WGS to gain a better understanding of the biology of N. meningitidis and the epidemiology of IMD in Lithuania. Initially, we observed that the analyzed strains harbored a genome of approximately 2.2 million bases and a GC content of 51.7%, as previously described elsewhere (Caugant and Brynildsrud, 2019). KEGG analysis revealed highly similar pathway modules among the strains, with only minor differences observed. We found that two N. meningitidis strains displayed incomplete pathways for Shikimate and Siroheme biosynthesis, potentially affecting their metabolic capabilities and nutritional requirements. Additionally, only three strains possessed a complete pathway for dTDP-L-rhamnose biosynthesis. dTDP-L-rhamnose is crucial for building cell surface structures essential for bacterial interactions with the environment, including the host immune system (van der Beek et al., 2019). Further investigation of the specific genetic differences associated with this pathway in strains with complete and incomplete pathways could provide insights into the molecular basis of these variations and their potential impact on the biology, adaptation, and pathogenicity of N. meningitidis.
The initial bacterium-host interaction relies on adhesion, where specific bacterial surface molecules (adhesins) bind to host cell receptors. Various surface structures like pilus, opacity-associated proteins (Opa and Opc), autotransporter adhesins (App, MspA/AusI, NadA, and NhhA), two-partner secretion systems (HrpA and HrpB) play key roles. Additionally, other surface structures like polysaccharide capsules, lipo-oligosaccharides, and porins also contribute to adhesion (Hung and Christodoulides, 2013). Our results revealed combinations of adhesion domains and possibly adhesion-related domains in N. meningitidis isolates from Lithuania.
Previous studies have indicated that approximately 17% of N. meningitidis strains possess a Gonococcal Genetic Island (GGI). However, some strains exhibit multiple insertions and deletions within the GGI, whereas others harbor intact T4SS genes, potentially leading to the production of functional secretion systems (Woodhams et al., 2012). During the domain analysis, we identified a strain with a unique combination of domains that was not found in the other strains examined. The domains identified in strain ID 120139 (TraL, TraE, TraK, TraC, TraU, type-F conjugative transfer system pilin assembly protein, F plasmid transfer operon protein, TraG-like protein, and N-terminal region) were encoded by GGI. Although it has been suggested that GGI is absent in serogroups A, B, and Y (Woodhams et al., 2012), our study found specific GGI sequences in the N. meningitidis serogroup Y.
The analyzed isolates possessed the essential virulence factors required for effective colonization and pathogenicity, affirming their disease-causing potential. The outer membrane vesicles, NhhA, and the capsules are among the most widely recognized and extensively studied virulence factors of N. meningitidis (Joshi and Saroj, 2023). According to the VFDB, the analyzed strains possessed virulence factors not commonly found in N. meningitidis, such as types of endotoxins (LOS) found in the genus Haemophilus and a capsule-associated virulence factor for antiphagocytosis found in the genus Vibrio. In this study, 82 genes linked to virulence were identified, most of which were associated with adherence and iron uptake, which is consistent with the well-established dependence of N. meningitidis growth on iron availability.
In addition to virulence factors, the analyzed isolates contained various antibiotic-resistance genes, providing resistance to multiple classes of antibiotics. penA gene mosaic alleles, characterized by four or five amino acid substitutions, have been shown to induce intermediate susceptibility to penicillins (Taha et al., 2007). Three isolates in our study harbored alterations in penA, encoding penicillin-binding protein 2, carrying E464A, E469K, N472E, F504L, A510V, I515V, H541N, A549T and I566V substitutions. These amino acid sites have been previously linked to decreased susceptibility to beta-lactam antibiotics, such as penicillin and cephalosporins (Hao et al., 2011). The isolate with the penA52 allele, for which the penicillin MIC was 0.125 μg/mL, had an asparagine insertion T573_A574insN in its penA gene. The significance of the Asn insertion in PBP2 is unclear (Du Plessis et al., 2008). To investigate the association between the asparagine insertion and penicillin susceptibility, we analyzed penA gene sequences from 209 N. meningitidis isolates with penicillin MICs above 0.25 μg/mL and 137 isolates with penicillin MICs equal to or below 0.016 μg/mL, sourced from the pubMLST database. Our findings indicate that 70% of the penicillin-resistant isolates contained an additional asparagine (AAT) codon in their penA genes. In contrast, none of the penicillin-susceptible isolates possessed this insertion (data not shown).
Another mechanism leading to penicillin resistance is the presence of bla genes that encode beta-lactamases (Tsang et al., 2019). The blaROB-1 gene was not present in any of the analyzed isolates. Studies have shown that resistance to ciprofloxacin can be induced by mutations in parC or the quinolone resistance-determining region of gyrA (Chen et al., 2020), while resistance to chemoprophylactic agents, such as rifampicin, due to mutations in rpoB has also been documented (Taha et al., 2010). No alleles were associated with phenotypic resistance to fluoroquinolones (gyrA, NEIS1320, NEIS1525, and NEIS1600) or rifampicin (NEIS0123 and rpoB). In the current study, we identified N. meningitidis strains with novel penA, NEIS0123, NEIS1320, NEIS1525, NEIS1600, and NEIS1753 locus variants. However, further exploration of antibacterial resistance using phenotypic and transcriptomic analyses is necessary to obtain a comprehensive understanding of how newly detected gene alleles correlate with antimicrobial sensitivity.
While N. meningitidis remains susceptible to antibiotics employed for the treatment and prevention of IMD, concerns persist regarding reduced antibiotic susceptibility (Rostamian et al., 2022). In our study, none of the analyzed isolates exhibited phenotypic resistance to penicillin, cefotaxime, rifampicin, or ciprofloxacin. However, the identification of several strains with genes associated with antimicrobial resistance raises the concern that resistance may emerge in the future, potentially altering the epidemiology of IMD in Lithuania.
In summary, this study evaluates IMD trends in Lithuania from 2009 to 2021. However, it has limitations. Firstly, the relatively small number of available genomes for WGS analysis may have limited the detection of unique genetic characteristics specific to strains circulating in Lithuania. Secondly, the data collected from a limited number of sources did not reflect the prevalence of N. meningitidis among carriers. Another limitation of this study relates to our genome assemblies being based on short-read sequencing only. This may introduce the possibility that some genes were not detected due to the incompleteness of the genome. However, our draft genomes exhibited high quality indicators (low contig number, expected genome size, and high coverage), which gives us confidence in our reported results. In future studies, PCR targeting the regions of interest or long-read sequencing technologies such as Nanopore sequencing, capable of generating ultra-long (>4Mb) reads, could be employed to enhance the reconstruction and characterization of genes in N. meningitidis isolates. Consequently, it is challenging to determine the distinct characteristics of MenB CC32 genomes in Lithuania, as observed through WGS, which distinguishes them from MenB CC32 and nonvirulent strains found in other regions. This limitation hinders our ability to reliably explain variations in virulence and pathogenicity. Finally, the identified genetic virulence, pathogenicity, and antibiotic resistance determinants have not been experimentally confirmed.
To the best of our knowledge, this is the first study to explore the genetic characteristics of N. meningitidis isolates from Lithuania and to investigate the genotypic relationship of Lithuanian isolates with strains isolated in Europe, with the aim of determining the relatedness of Lithuanian isolates based on core-genome analysis. Finally, this study enriches pubMLST database with WGS data from Lithuanian isolates. While Lithuania has not experienced any outbreaks thus far, it is essential to prioritize the molecular epidemiological surveillance of N. meningitidis as hypervirulent strains continue to emerge.
Acknowledgments
We would like to thank Editage (www.editage.com) for English language editing. During the preparation of this work the authors used ChatGPT 3.5 in order to improve readability and language. After using this tool/service, the authors reviewed and edited the content as needed and takes full responsibility for the content of the publication.
Funding Statement
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Data availability statement
The datasets generated and analyzed in this study have been deposited in the Public Databases for Molecular Typing and Microbial Genome Diversity (PubMLST). The genome sequences are accessible at the following link: https://pubmlst.org/bigsdb?db=pubmlst_neisseria_isolates&page=query&genomes=1, with the accession numbers as follows: 119504, 120132, 120133, 120134, 120135, 120136, 120137, 120138, 120139, 120140.
Ethics statement
This study uses strains obtained from the National Public Health Surveillance Laboratory. The Lithuanian Bioethics Committee did not require the study to be reviewed or approved by an ethics committee because it did not involve human biological samples or patient-related information. This retrospective study exclusively used pure cultures of microorganisms, with each isolate sample encrypted and identified by a unique code to ensure anonymity. Under Lithuanian law, the use of microbial cultures in this study does not fall under the scope of biomedical research. It is important to note that the isolates used were collected as part of national-level pathogen epidemiological surveillance, conducted in accordance with Order No. V-1194 issued by the Ministry of Health of the Republic of Lithuania on December 18, 2013.
Author contributions
AS: Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing. MK: Formal analysis, Writing – review & editing. AK: Investigation, Writing – review & editing. GV: Writing – review & editing. PS: Data curation, Formal analysis, Writing – review & editing. JB: Writing – review & editing. KT: Investigation, Writing – review & editing. AP: Writing – review & editing. NK: Methodology, Project administration, Supervision, Writing – review & editing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2024.1432197/full#supplementary-material
References
- Acevedo R., Bai X., Borrow R., Caugant D. A., Carlos J., Ceyhan M., et al. . (2019). The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev. Vaccines 18, 15–30. 10.1080/14760584.2019.1557520 [Abstract] [CrossRef] [Google Scholar]
- Alcock B. P., Raphenya A. R., Lau T. T. Y., Tsang K. K., Bouchard M., Edalatmand A., et al. . (2020). CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 48, D517. 10.1093/NAR/GKZ935 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Alderson M. R., Arkwright P. D., Bai X., Black S., Borrow R., Caugant D. A., et al. . (2022). Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review. J. Infect. 84, 289–296. 10.1016/j.jinf.2021.11.016 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Antignac A., Alonso J.-M., Taha M.-K. (2001). Nonculture prediction of neisseria meningitidis susceptibility to penicillin. Antimicrob. Agents Chemother. 45, 3625–3628. 10.1128/AAC.45.12.3625-3628.2001 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Bennett D. E., Cafferkey M. T. (2003). Multilocus restriction typing: A tool for Neisseria meningitidis strain discrimination. J. Med. Microbiol. 52, 781–787. 10.1099/jmm.0.05225-0 [Abstract] [CrossRef] [Google Scholar]
- Bennett D. E., Meyler K. L., Cafferkey M. T., Cunney R. J. (2020). Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period 1996-2015. PloS One 15, e0228629. 10.1371/journal.pone.0228629 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Bratcher H. B., Corton C., Jolley K. A., Parkhill J., Maiden M. C. J. (2014). A gene-by-gene population genomics platform: De novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes. BMC Genomics 15, 1–16. 10.1186/1471-2164-15-1138 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Brueggemann A. B., Jansen van Rensburg M. J., Shaw D., McCarthy N. D., Jolley K. A., Maiden M. C. J., et al. . (2021). Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a. Lancet Digit. Heal 3, e360. 10.1016/S2589-7500(21)00077-7 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Caugant D. A., Brynildsrud O. B. (2019). Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis. Nat. Rev. Microbiol. 18, 84–96. 10.1038/s41579-019-0282-6 [Abstract] [CrossRef] [Google Scholar]
- Caugant D. A., Maiden M. C. J. (2009). Meningococcal carriage and disease—Population biology and evolution. Vaccine 27, B64. 10.1016/J.VACCINE.2009.04.061 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Chen M., Zhang C., Zhang X., Chen M. (2020). Meningococcal quinolone resistance originated from several commensal neisseria species. Antimicrob. Agents Chemother. 64, e01494-19. 10.1128/AAC.01494-19 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Cosentino S., Voldby Larsen M., Møller Aarestrup F., Lund O. (2013). PathogenFinder - distinguishing friend from foe using bacterial whole genome sequence data. PloS One 8, e77302. 10.1371/JOURNAL.PONE.0077302 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Du Plessis M., Von Gottberg A., Cohen C., De Gouveia L., Klugman K. P. (2008). Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J. Clin. Microbiol. 46, 3208. 10.1128/JCM.00221-08 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- European Centre for Disease Prevention and Control (2023). Surveillance Atlas of Infectious Diseases. Available online at: https://atlas.ecdc.europa.eu/public/index.aspx (Accessed November 6, 2023).
- Eybpoosh S., Haghdoost A. A., Mostafavi E., Bahrampour A., Azadmanesh K., Zolala F. (2017). Molecular epidemiology of infectious diseases. Electron. Physician 9, 5149. 10.19082/5149 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Garcia-Vallvé S., Palau J., Romeu A. (1999). Horizontal Gene Transfer in Glycosyl Hydrolases Inferred from Codon Usage in Escherichia coli and Bacillus subtilis. Mol. Biol. Evol. 16, 1125–1134. 10.1093/oxfordjournals.molbev.a026203 [Abstract] [CrossRef] [Google Scholar]
- Hao W., Ma J. H., Warren K., Tsang R. S. W., Low D. E., Jamieson F. B., et al. . (2011). Extensive Genomic Variation within Clonal Complexes of Neisseria meningitidis. Genome Biol. Evol. 3, 1406. 10.1093/GBE/EVR119 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Hedberg S. T., Fredlund H., Nicolas P., Caugant D. A., Olcén P., Unemo M. (2009). Antibiotic susceptibility and characteristics of neisseria meningitidis isolates from the african meningitis belt 2000 to 2006: phenotypic and genotypic perspectives. Antimicrob. Agents Chemother. 53, 1561. 10.1128/AAC.00994-08 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Hong E., Deghmane A. E., Taha M. K. (2018). Acquisition of Beta-Lactamase by Neisseria meningitidis through Possible Horizontal Gene Transfer. Antimicrob. Agents Chemother. 62, e00831-18. 10.1128/AAC.00831-18 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Hung M. C., Christodoulides M. (2013). The biology of neisseria adhesins. Biol. (Basel) 2, 1054. 10.3390/BIOLOGY2031054 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Ivaškevičienė I., Silickaitė J., Mačionienė A., Ivaškevičius R., Bulavaitė A., Gėgžna V., et al. . (2023). Molecular characteristics of Neisseria meningitidis carriage strains in university students in Lithuania. BMC Microbiol. 23, 1–9. 10.1186/S12866-023-03111-5 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Jolley K. A., Bray J. E., Maiden M. C. J. (2018). Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 3, 124. 10.12688/WELLCOMEOPENRES.14826.1 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Jolley K. A., Brehony C., Maiden M. C. J. (2007). Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol. Rev. 31, 89–96. 10.1111/J.1574-6976.2006.00057.X [Abstract] [CrossRef] [Google Scholar]
- Joshi R., Saroj S. D. (2023). Survival and evasion of Neisseria meningitidis from macrophages. Med. Microecol 17, 100087. 10.1016/J.MEDMIC.2023.100087 [CrossRef] [Google Scholar]
- Kanehisa M., Sato Y., Morishima K. (2016). BlastKOALA and ghostKOALA: KEGG tools for functional characterization of genome and metagenome sequences. J. Mol. Biol. 428, 726–731. 10.1016/J.JMB.2015.11.006 [Abstract] [CrossRef] [Google Scholar]
- Letunic I., Bork P. (2021). Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 49, W293–W296. 10.1093/nar/gkab301 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Liu B., Zheng D., Jin Q., Chen L., Yang J. (2019). VFDB 2019: a comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res. 47, D687. 10.1093/NAR/GKY1080 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Lu Q. F., Cao D. M., Su L. L., Li S. B., Ye G.-B., Zhu X. Y., et al. . (2019). Genus-wide comparative genomics analysis of neisseria to identify new genes associated with pathogenicity and niche adaptation of neisseria pathogens. Int. J. Genomics 2019, 6015730. 10.1155/2019/6015730 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Maiden M. C. J., Bygraves J. A., Feil E., Morelli G., Russell J. E., Urwin R., et al. . (1998). Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenicmicroorganisms. Proc. Natl. Acad. Sci. 95, 3140–3145. 10.1073/PNAS.95.6.3140 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Mikucki A., McCluskey N. R., Kahler C. M. (2022). The host-pathogen interactions and epicellular lifestyle of neisseria meningitidis. Front. Cell. Infect. Microbiol. 12. 10.3389/FCIMB.2022.862935 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Mistry J., Chuguransky S., Williams L., Qureshi M., Salazar G. A., Sonnhammer E. L. L., et al. . (2021). Pfam: The protein families database in 2021. Nucleic Acids Res. 49, D412–D419. 10.1093/NAR/GKAA913 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Mullally C. A., Mikucki A., Wise M. J., Kahler C. M. (2021). Modelling evolutionary pathways for commensalism and hypervirulence in Neisseria meningitidis. Microb. Genomics 7, 662. 10.1099/MGEN.0.000662 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Nadel S. (2016). Treatment of meningococcal disease. J. Adolesc. Heal 59, S21–S28. 10.1016/J.JADOHEALTH.2016.04.013 [Abstract] [CrossRef] [Google Scholar]
- Overbeek R., Olson R., Pusch G. D., Olsen G. J., Davis J. J., Disz T., et al. . (2014). The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res. 42, D206. 10.1093/NAR/GKT1226 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Paysan-Lafosse T., Blum M., Chuguransky S., Grego T., Pinto B. L., Salazar G. A., et al. . (2023). InterPro in 2022. Nucleic Acids Res. 51, D418–D427. 10.1093/NAR/GKAC993 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Purushothaman S., Meola M., Egli A. (2022). Combination of whole genome sequencing and metagenomics for microbiological diagnostics. Int. J. Mol. Sci. 23, 9834. 10.3390/IJMS23179834 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Rodgers E., Bentley S. D., Borrow R., Bratcher H. B., Brisse S., Brueggemann A. B., et al. . (2020). The global meningitis genome partnership. J. Infect. 81, 510–520. 10.1016/j.jinf.2020.06.064 [Abstract] [CrossRef] [Google Scholar]
- Rodrigues C. M. C., Jolley K. A., Smith A., Claire Cameron J., Feavers I. M., Maiden M. C. J. (2021). Meningococcal deduced vaccine antigen reactivity (MenDeVAR) index: a rapid and accessible tool that exploits genomic data in public health and clinical microbiology applications. J. Clin. Microbiol. 59, e02161-20. 10.1128/JCM.02161-20 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Rostamian M., Chegene Lorestani R., Jafari S., Mansouri R., Rezaeian S., Ghadiri K., et al. . (2022). A systematic review and meta-analysis on the antibiotic resistance of Neisseria meningitidis in the last 20 years in the world. Indian J. Med. Microbiol. 40, 323–329. 10.1016/J.IJMMB.2022.05.005 [Abstract] [CrossRef] [Google Scholar]
- Schoen C., Tettelin H., Parkhill J., Frosch M. (2009). Genome flexibility in Neisseria meningitidis. Vaccine 27, B103. 10.1016/J.VACCINE.2009.04.064 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Sereikaitė E., Plepytė R., Petrutienė A., Stravinskienė D., Kučinskaitė-Kodzė I., Gėgžna V., et al. . (2023). Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania, (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage. Front. Cell. Infect. Microbiol. 13. 10.3389/FCIMB.2023.1136211/BIBTEX [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Soeters H. M., McNamara L. A., Blain A. E., Whaley M., MacNeil J. R., Hariri S., et al. . (2019). University-based outbreaks of meningococcal disease caused by serogroup B, United States 2013–2018. Emerg. Infect. Dis. 25, 434–440. 10.3201/EID2503.181574 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Stephens D. S., Greenwood B., Brandtzaeg P. (2007). Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369, 2196–2210. 10.1016/S0140-6736(07)61016-2 [Abstract] [CrossRef] [Google Scholar]
- Taha M. K., Hedberg S. T., Szatanik M., Hong E., Ruckly C., Abad R., et al. . (2010). Multicenter Study for Defining the Breakpoint for Rifampin Resistance in Neisseria meningitidis by rpoB Sequencing. Antimicrob. Agents Chemother. 54, 3651. 10.1128/AAC.00315-10 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Taha M. K., Vázquez J. A., Hong E., Bennett D. E., Bertrand S., Bukovski S., et al. . (2007). Target gene sequencing to characterize the penicillin G susceptibility of neisseria meningitidis. Antimicrob. Agents Chemother. 51, 2784. 10.1128/AAC.00412-07 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Thabuis A., Tararbit K., Taha M. K., Dejour-Salamanca D., Ronin V., du Chatelet I. P., et al. . (2018). Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination. Eurosurveillance 23, 1700590. 10.2807/1560-7917.ES.2018.23.28.1700590 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- The European Committee on Antimicrobial Susceptibility Testing (2023). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 13.1. Available online at: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_13.1_Breakpoint_Tables.pdf (Accessed June 29, 2023).
- Tsang R. S. W., Ahmad T., Jamieson F. B., Tyrrell G. J. (2019). WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 β-lactamase gene. J. Antimicrob. Chemother. 74, 22–28. 10.1093/JAC/DKY391 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Tzeng Y.-L., Stephens D. S. (2021). A narrative review of the W, X, Y, E, and NG of meningococcal disease: emerging capsular groups, pathotypes, and global control. Microorganisms 9, 519. 10.3390/microorganisms9030519 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- van der Beek S. L., Zorzoli A., Çanak E., Chapman R. N., Lucas K., Meyer B. H., et al. . (2019). Streptococcal dTDP‐L‐rhamnose biosynthesis enzymes: functional characterization and lead compound identification. Mol. Microbiol. 111, 951. 10.1111/MMI.14197 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Waterhouse A. M., Procter J. B., Martin D. M. A., Clamp M., Barton G. J. (2009). Jalview Version 2—a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189–1191. 10.1093/BIOINFORMATICS/BTP033 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Woodhams K. L., Benet Z. L., Blonsky S. E., Hackett K. T., Dillard J. P. (2012). Prevalence and detailed mapping of the gonococcal genetic island in neisseria meningitidis. J. Bacteriol 194, 2275. 10.1128/JB.00094-12 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Yu N. Y., Wagner J. R., Laird M. R., Melli G., Rey S., Lo R., et al. . (2010). PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26, 1608. 10.1093/BIOINFORMATICS/BTQ249 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Zhu H., Wang Q., Wen L., Xu J., Shao Z., Chen M., et al. . (2012). Development of a multiplex PCR assay for detection and genogrouping of neisseria meningitidis. J. Clin. Microbiol. 50, 46–51. 10.1128/JCM.00918-11 [Europe PMC free article] [Abstract] [CrossRef] [Google Scholar]
- Zografaki I., Detsis M., Del Amo M., Iantomasi R., Maia A., Montuori E. A., et al. . (2023). Invasive meningococcal disease epidemiology and vaccination strategies in four Southern European countries: a review of the available data. Expert Rev. Vaccines 22, 545–562. 10.1080/14760584.2023.2225596 [Abstract] [CrossRef] [Google Scholar]
Articles from Frontiers in Cellular and Infection Microbiology are provided here courtesy of Frontiers Media SA
Citations & impact
This article has not been cited yet.
Impact metrics
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/169303831
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.
Hum Vaccin Immunother, 20(1):2378537, 22 Jul 2024
Cited by: 0 articles | PMID: 39037011
Surveillance of invasive meningococcal disease based on whole genome sequencing (WGS), Czech Republic, 2015.
Epidemiol Mikrobiol Imunol, 67(2):64-73, 01 Jan 2018
Cited by: 3 articles | PMID: 30126283
Demographic Features of Invasive Meningococcal Disease in Taiwan, 1993 to 2020, and Genetic Characteristics of Neisseria meningitidis Isolates, 2003 to 2020.
Microbiol Spectr, 10(4):e0088222, 11 Jul 2022
Cited by: 3 articles | PMID: 35862973 | PMCID: PMC9430714
Molecular Characterization of Invasive Isolates of Neisseria meningitidis in Casablanca, Morocco.
J Clin Microbiol, 56(7):e00445-18, 25 Jun 2018
Cited by: 6 articles | PMID: 29743304 | PMCID: PMC6018341